Li Duan1, Yudi Xie2, Qiang Wang3, Xianli Sun1, Wenlong Guan1, Jun Xu1, Zhiqiang Lin1, Quan Wang1, Ying Qin1, Chi Zhang1, Yuanda Li1, Xiaojuan Qu1, Ling Li2, Jianping Li4, Guoyue Lin1. 1. The Eighth Affiliated Hospital of Xinjiang Medical University Urumqi 830013, Xinjiang, China. 2. Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College Chengdu 610052, Sichuan, China. 3. Department of Dermatology, Seventh Peoples Hospital of Shenyang Shenyang 110003, Liaoning, China. 4. Liaoning Blood Center Shenyang 110044, Liaoning, China.
Abstract
PURPOSE: To investigate changes in the production of IgM and IgG antibodies and the negative transformation of viral nucleic acids in COVID-19 patients after convalescent plasma therapy, and also to discuss the clinical therapeutic effect, so as to provide a basis for the treatment of COVID-19 using specific antibodies. METHODS: The convalescent plasma of recovered patients from COVID-19 was used to treat other patients, and the levels of antibodies IgM and IgG and the nucleic acid genes ORF1ab and N in the patients were tested regularly for statistical comparison and analysis. RESULTS: In general, the Ct value and concentration of IgM and IgG antibodies in the plasma infusion group were significantly higher (1-3 times higher) than those in the non-plasma infusion group, respectively, but these differences were not significant (P>0.05). However, the content of antibodies in severe patients in the plasma transfusion group was significantly higher than those in the non-plasma transfusion group at discharge, the results being statistically significant (P<0.05). CONCLUSIONS: The application of convalescent plasma significantly increases the antibody content in severe and critical inpatients, effectively enhances immune function, accelerates the clearance of virus and the nucleic acid negative conversion rate, and significantly promotes early improvement in COVID-19 patients. AJTR
PURPOSE: To investigate changes in the production of IgM and IgG antibodies and the negative transformation of viral nucleic acids in COVID-19 patients after convalescent plasma therapy, and also to discuss the clinical therapeutic effect, so as to provide a basis for the treatment of COVID-19 using specific antibodies. METHODS: The convalescent plasma of recovered patients from COVID-19 was used to treat other patients, and the levels of antibodies IgM and IgG and the nucleic acid genes ORF1ab and N in the patients were tested regularly for statistical comparison and analysis. RESULTS: In general, the Ct value and concentration of IgM and IgG antibodies in the plasma infusion group were significantly higher (1-3 times higher) than those in the non-plasma infusion group, respectively, but these differences were not significant (P>0.05). However, the content of antibodies in severe patients in the plasma transfusion group was significantly higher than those in the non-plasma transfusion group at discharge, the results being statistically significant (P<0.05). CONCLUSIONS: The application of convalescent plasma significantly increases the antibody content in severe and critical inpatients, effectively enhances immune function, accelerates the clearance of virus and the nucleic acid negative conversion rate, and significantly promotes early improvement in COVID-19 patients. AJTR
Authors: Zhongyu Zhu; Antony S Dimitrov; Samitabh Chakraborti; Dimana Dimitrova; Xiaodong Xiao; Christopher C Broder; Dimiter S Dimitrov Journal: Expert Rev Anti Infect Ther Date: 2006-02 Impact factor: 5.091
Authors: K Mupapa; M Massamba; K Kibadi; K Kuvula; A Bwaka; M Kipasa; R Colebunders; J J Muyembe-Tamfum Journal: J Infect Dis Date: 1999-02 Impact factor: 5.226
Authors: Y Cheng; R Wong; Y O Y Soo; W S Wong; C K Lee; M H L Ng; P Chan; K C Wong; C B Leung; G Cheng Journal: Eur J Clin Microbiol Infect Dis Date: 2005-01 Impact factor: 3.267
Authors: James D Mellor; Michael P Brown; Helen R Irving; John R Zalcberg; Alexander Dobrovic Journal: J Hematol Oncol Date: 2013-01-04 Impact factor: 17.388
Authors: Ilse Jongerius; Leendert Porcelijn; Anna E van Beek; John W Semple; C Ellen van der Schoot; Alexander P J Vlaar; Rick Kapur Journal: Transfus Med Rev Date: 2019-10-18